{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:23:00Z","timestamp":1792095780929,"version":"4.4.0"},"reference-count":303,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.addr.2026.115854","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T15:47:32Z","timestamp":1773589652000},"page":"115854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Protein stability and viscosity in molecularly crowded high-concentration biologics"],"prefix":"10.1016","volume":"233","author":[{"given":"Zhaoxi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshil K.","family":"Renawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Peter","family":"Wuelfing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Buist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izzat","family":"Raheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Givand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra B.","family":"Gabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubi","family":"Burlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"939","key":"10.1016\/j.addr.2026.115854_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/pmj.2003.010421","article-title":"Intravenous therapy","volume":"80","author":"Waitt","year":"2004","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.addr.2026.115854_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/DDDT.S287323","article-title":"Subcutaneous delivery of high-dose\/volume biologics: current status and prospect for future advancements","volume":"15","author":"Badkar","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40271-014-0075-y","article-title":"Intravenous versus subcutaneous drug administration. Which do patients prefer? A systematic review","volume":"8","author":"Stoner","year":"2015","journal-title":"The Patient-Patient-Centered Outcomes Research"},{"key":"10.1016\/j.addr.2026.115854_bb0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2147\/CEOR.S317687","article-title":"Payer perspectives on intravenous versus subcutaneous administration of drugs","author":"Epstein","year":"2021","journal-title":"ClinicoEconomics and Outcomes Research"},{"issue":"9","key":"10.1016\/j.addr.2026.115854_bb0025","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2023-0171","article-title":"Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis","volume":"13","author":"Bril","year":"2024","journal-title":"Journal of Comparative Effectiveness Research"},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/NAN.0b013e31824d2271","article-title":"Subcutaneous drug delivery: a route to increased safety, patient satisfaction, and reduced costs","volume":"35","author":"Dychter","year":"2012","journal-title":"J. Infus. Nurs."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40259-018-0295-0","article-title":"Subcutaneous administration of biotherapeutics: an overview of current challenges and opportunities","volume":"32","author":"Bittner","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.addr.2026.115854_bb0040","doi-asserted-by":"crossref","first-page":"2205540","DOI":"10.1080\/19420862.2023.2205540","article-title":"A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations","volume":"15","author":"Ghosh","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.addr.2026.115854_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103914","article-title":"Development roadmap for subcutaneous delivery of high dose biologics-high concentration formulation, analytical comparability and patient preference considerations for large volume devices","author":"Ghosh","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0050","first-page":"1","article-title":"Developing high-concentration monoclonal antibody formulations for subcutaneous administration to improve patient treatment","author":"Mijangos","year":"2025","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.addr.2026.115854_bb0060","first-page":"473","article-title":"Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance","author":"Berteau","year":"2015","journal-title":"Med. Devices Evid. Res."},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb0065","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.xphs.2016.05.029","article-title":"Subcutaneous injection volume of biopharmaceuticals\u2014pushing the boundaries","volume":"105","author":"Mathaes","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1208\/s12249-021-01949-4","article-title":"Container closure and delivery considerations for intravitreal drug administration","volume":"22","author":"Parenky","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0075","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jps.20079","article-title":"Challenges in the development of high protein concentration formulations","volume":"93","author":"Shire","year":"2004","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0080","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.xphs.2021.11.008","article-title":"Ongoing challenges to develop high concentration monoclonal antibody-based formulations for subcutaneous administration: quo vadis?","volume":"111","author":"Jiskoot","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0085","doi-asserted-by":"crossref","first-page":"2285277","DOI":"10.1080\/19420862.2023.2285277","article-title":"Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume","volume":"15","author":"Desai","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.addr.2026.115854_bb0090","doi-asserted-by":"crossref","first-page":"2211185","DOI":"10.1080\/19420862.2023.2211185","article-title":"High concentration formulation developability approaches and considerations","volume":"15","author":"Zarzar","year":"2023","journal-title":"MAbs"},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1208\/s12248-025-01132-8","article-title":"Insights from a survey of drug formulation experts: challenges and preferences in high-concentration subcutaneous biologic drug development","volume":"27","author":"Desai","year":"2025","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0100","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.xphs.2018.01.007","article-title":"Challenges and opportunities for the subcutaneous delivery of therapeutic proteins","volume":"107","author":"Turner","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb0105","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4155\/tde.12.68","article-title":"High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry perspective","volume":"3","author":"Narasimhan","year":"2012","journal-title":"Ther. Deliv."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.xphs.2015.11.002","article-title":"Immunogenicity of therapeutic protein aggregates","volume":"105","author":"Moussa","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.copbio.2014.08.001","article-title":"Protein aggregation and its impact on product quality","volume":"30","author":"Roberts","year":"2014","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2026.115854_bb0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-08-100296-4.00009-9","article-title":"The molecular basis of high viscosity of monoclonal antibodies (mAbs) at high concentration","author":"Shire","year":"2015","journal-title":"Monoclon. Antib."},{"issue":"27","key":"10.1016\/j.addr.2026.115854_bb0125","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1039\/C5SM00513B","article-title":"Impact of aggregate formation on the viscosity of protein solutions","volume":"11","author":"Nicoud","year":"2015","journal-title":"Soft Matter"},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb0130","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/bip.1981.360201006","article-title":"Excluded volume as a determinant of macromolecular structure and reactivity","volume":"20","author":"Minton","year":"1981","journal-title":"Biopolymers: Original Research on Biomolecules"},{"issue":"14","key":"10.1016\/j.addr.2026.115854_bb0135","doi-asserted-by":"crossref","first-page":"10577","DOI":"10.1074\/jbc.R100005200","article-title":"The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media","volume":"276","author":"Minton","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpj.2008.10.014","article-title":"Macromolecular crowding modulates folding mechanism of \u03b1\/\u03b2 protein apoflavodoxin","volume":"96","author":"Homouz","year":"2009","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0145","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11095-024-03673-7","article-title":"Unraveling pre-filled syringe needle clogging: exploring a fresh outlook through innovative techniques","volume":"41","author":"Hu","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2026.115854_bb0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejpb.2022.05.009","article-title":"Needle clogging of protein solutions in prefilled syringes: a two-stage process with various determinants","volume":"176","author":"Scheler","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2026.115854_bb0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejpb.2018.05.006","article-title":"On the needle clogging of staked-in-needle pre-filled syringes: mechanism of liquid entering the needle and solidification process","volume":"128","author":"De Bardi","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb0160","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1002\/jps.22190","article-title":"Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies","volume":"99","author":"Yadav","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/19420862.2015.1128606","article-title":"Molecular basis of high viscosity in concentrated antibody solutions: strategies for high concentration drug product development","volume":"8","author":"Tomar","year":"2016","journal-title":"MAbs"},{"issue":"13","key":"10.1016\/j.addr.2026.115854_bb0170","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.addr.2011.09.008","article-title":"Viscosity of concentrated therapeutic protein compositions","volume":"63","author":"Jezek","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0175","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/17425247.2023.2219891","article-title":"Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions","volume":"20","author":"Schneider","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.addr.2026.115854_bb0180","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/17425247.2022.2116425","article-title":"Enabling faster subcutaneous delivery of larger volume, high viscosity fluids","volume":"19","author":"Rini","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2026.115854_bb0185","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijpharm.2018.11.012","article-title":"Injectability as a function of viscosity and dosing materials for subcutaneous administration","volume":"554","author":"Watt","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/jop.2010.0082","article-title":"Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection","volume":"27","author":"Rodrigues","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.addr.2026.115854_bb0195","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s12325-019-01101-6","article-title":"Subcutaneous injection of drugs: literature review of factors influencing pain sensation at the injection site","volume":"36","author":"Usach","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.addr.2026.115854_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coche.2017.04.001","article-title":"Recent progresses of understanding the viscosity of concentrated protein solutions","volume":"16","author":"Zhang","year":"2017","journal-title":"Curr. Opin. Chem. Eng."},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0205","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/acs.chemrev.3c00615","article-title":"Molecular crowding: the history and development of a scientific paradigm","volume":"124","author":"Alfano","year":"2024","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0210","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0959-440X(00)00172-X","article-title":"Macromolecular crowding: an important but neglected aspect of the intracellular environment","volume":"11","author":"Ellis","year":"2001","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0215","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1110\/ps.0235703","article-title":"Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor","volume":"12","author":"Chi","year":"2003","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0220","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.biophys.37.032807.125817","article-title":"Macromolecular crowding and confinement: biochemical, biophysical, and potential physiological consequences","volume":"37","author":"Zhou","year":"2008","journal-title":"Annu. Rev. Biophys."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev-biophys-091321-071829","article-title":"Macromolecular crowding is more than hard-core repulsions","volume":"51","author":"Speer","year":"2022","journal-title":"Annu. Rev. Biophys."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0230","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/molecules20011377","article-title":"Beyond the excluded volume effects: mechanistic complexity of the crowded milieu","volume":"20","author":"Kuznetsova","year":"2015","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb0235","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/1389203719666171213114919","article-title":"Viscosity control of protein solution by small solutes: a review","volume":"19","author":"Hong","year":"2018","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0240","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4161\/19420862.2014.985504","article-title":"Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions","volume":"7","author":"Nichols","year":"2015","journal-title":"MAbs"},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103877","article-title":"Current and emerging strategies for subcutaneous delivery of high-concentration and high-dose antibody therapeutics","volume":"114","author":"Ren","year":"2025","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.addr.2026.115854_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2006.12.007","article-title":"Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects","volume":"127","author":"Arakawa","year":"2007","journal-title":"Biophys. Chem."},{"issue":"13","key":"10.1016\/j.addr.2026.115854_bb0255","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.addr.2011.06.014","article-title":"Molecular level insight into intra-solvent interaction effects on protein stability and aggregation","volume":"63","author":"Shukla","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0260","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1021\/mp5000218","article-title":"Specific decrease in solution viscosity of antibodies by arginine for therapeutic formulations","volume":"11","author":"Inoue","year":"2014","journal-title":"Mol. Pharm."},{"issue":"43","key":"10.1016\/j.addr.2026.115854_bb0265","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/acs.iecr.6b02042","article-title":"Viscosity reduction of a concentrated monoclonal antibody with arginine\u00b7 HCl and arginine\u00b7 glutamate","volume":"55","author":"Borwankar","year":"2016","journal-title":"Ind. Eng. Chem. Res."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/antib8040055","article-title":"Antibody structure and function: the basis for engineering therapeutics","volume":"8","author":"Chiu","year":"2019","journal-title":"Antibodies"},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0275","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/abt\/tbab027","article-title":"US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives","volume":"4","author":"Wang","year":"2021","journal-title":"Antibody therapeutics"},{"issue":"19","key":"10.1016\/j.addr.2026.115854_bb0280","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1021\/acs.jcim.3c00947","article-title":"Viscosity prediction of high-concentration antibody solutions with atomistic simulations","volume":"63","author":"Prass","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bpj.2012.04.047","article-title":"Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter","volume":"103","author":"Connolly","year":"2012","journal-title":"Biophys. J."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0290","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/mp300524x","article-title":"Rapid analysis of antibody self-association in complex mixtures using immunogold conjugates","volume":"10","author":"Sule","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115854_bb0295","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2304624","article-title":"In-situ biophysical characterization of high-concentration protein formulations using w NMR","volume":"16","author":"Song","year":"2024","journal-title":"MAbs"},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0300","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/biom14060617","article-title":"Sequence-based Viscosity prediction for rapid antibody engineering","volume":"14","author":"Estes","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.addr.2026.115854_bb0305","doi-asserted-by":"crossref","first-page":"2303781","DOI":"10.1080\/19420862.2024.2303781","article-title":"Reduction of monoclonal antibody viscosity using interpretable machine learning","volume":"16","author":"Makowski","year":"2024","journal-title":"MAbs"},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0310","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tips.2022.12.005","article-title":"Computational and artificial intelligence-based methods for antibody development","volume":"44","author":"Kim","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0315","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1517\/17425247.4.4.427","article-title":"Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration","volume":"4","author":"Frost","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0320","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/10717544.2018.1551442","article-title":"ENHANZE\u00ae drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20","volume":"26","author":"Locke","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2026.115854_bb0325","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2020.02.036","article-title":"Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics","volume":"321","author":"Collins","year":"2020","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb0330","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.1131899100","article-title":"Crystalline monoclonal antibodies for subcutaneous delivery","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0335","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s13346-018-0568-7","article-title":"Pressure and stress transients in autoinjector devices","volume":"8","author":"Veilleux","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0340","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jps.24184","article-title":"Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins","volume":"104","author":"Krayukhina","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103848","article-title":"Effect of silicone oil on the structure, stability, and aggregation of a therapeutic antibody","author":"Upadhyay","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0350","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejpb.2022.08.008","article-title":"Viscosity increase\/gelation of therapeutic IgG monoclonal antibodies induced by Zn(2+): one possible root cause of clogging of staked-in-needle prefilled syringes","volume":"178","author":"Fukuda","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2026.115854_bb0355","first-page":"1","article-title":"Investigating zinc migration from rigid needle shield to drug formulation in needle tip of pre-filled syringe","author":"Hu","year":"2025","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0360","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/bip.22163","article-title":"Quantitative assessment of the relative contributions of steric repulsion and chemical interactions to macromolecular crowding","volume":"99","author":"Minton","year":"2013","journal-title":"Biopolymers"},{"key":"10.1016\/j.addr.2026.115854_bb0365","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphy.2015.00045","article-title":"Biochemical reactions in crowded environments: revisiting the effects of volume exclusion with simulations","volume":"3","author":"Gomez","year":"2015","journal-title":"Front. Phys."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0370","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0022-2836(91)90499-V","article-title":"Estimation of macromolecule concentrations and excluded volume effects for the cytoplasm of Escherichia coli","volume":"222","author":"Zimmerman","year":"1991","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2026.115854_bb0375","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.exer.2016.03.009","article-title":"The cause and consequence of fiber cell compaction in the vertebrate lens","volume":"156","author":"Bassnett","year":"2017","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0380","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.exer.2008.08.018","article-title":"Protein\u2013protein interactions and lens transparency","volume":"87","author":"Takemoto","year":"2008","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0385","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1091\/mbc.e04-08-0742","article-title":"Cajal bodies, nucleoli, and speckles in the Xenopus oocyte nucleus have a low-density, sponge-like structure","volume":"16","author":"Handwerger","year":"2005","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0390","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/JB.181.1.197-203.1999","article-title":"Protein mobility in the cytoplasm of Escherichia coli","volume":"181","author":"Elowitz","year":"1999","journal-title":"J. Bacteriol."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0395","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/acs.chemrev.3c00622","article-title":"Macromolecular crowding, phase separation, and homeostasis in the orchestration of bacterial cellular functions","volume":"124","author":"Monterroso","year":"2024","journal-title":"Chem. Rev."},{"issue":"7019","key":"10.1016\/j.addr.2026.115854_bb0400","doi-asserted-by":"crossref","DOI":"10.1038\/nature03192","article-title":"Chemical space and biology","volume":"432","author":"Dobson","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000694","article-title":"Diffusion, crowding & protein stability in a dynamic molecular model of the bacterial cytoplasm","volume":"6","author":"McGuffee","year":"2010","journal-title":"PLoS Comput. Biol."},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb0410","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s00018-007-6451-1","article-title":"Viral capsids: mechanical characteristics, genome packaging and delivery mechanisms","volume":"64","author":"Roos","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb0415","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10495-018-1471-x","article-title":"Staurosporine-induced apoptotic water loss is cell-and attachment-specific","volume":"23","author":"Model","year":"2018","journal-title":"Apoptosis"},{"key":"10.1016\/j.addr.2026.115854_bb0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ddtec.2020.08.005","article-title":"Development challenges of high concentration monoclonal antibody formulations","volume":"37","author":"Koll\u00e1r","year":"2020","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.addr.2026.115854_bb0425","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejpb.2017.06.029","article-title":"High-concentration protein formulations: how high is high?","volume":"119","author":"Garidel","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.addr.2026.115854_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.03.041","article-title":"Nature and consequences of protein\u2013protein interactions in high protein concentration solutions","volume":"358","author":"Saluja","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0435","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jmr.699","article-title":"The effect of macromolecular crowding on protein aggregation and amyloid fibril formation","volume":"17","author":"Munishkina","year":"2004","journal-title":"J. Mol. Recognit."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0440","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2010.02.025","article-title":"Protein aggregation\u2014pathways and influencing factors","volume":"390","author":"Wang","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0445","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1021\/mp200566k","article-title":"The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions","volume":"9","author":"Yadav","year":"2012","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0450","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jps.23002","article-title":"Viscosity behavior of high-concentration protein mixtures","volume":"101","author":"Galush","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0455","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-0716-1450-1_4","article-title":"Assessment of therapeutic antibody developability by combinations of in vitro and in silico methods","volume":"2313","author":"Wolf Perez","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0460","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2007.05.015","article-title":"Folding versus aggregation: polypeptide conformations on competing pathways","volume":"469","author":"Jahn","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0465","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0959-440X(99)80012-8","article-title":"The fundamentals of protein folding: bringing together theory and experiment","volume":"9","author":"Dobson","year":"1999","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"6968","key":"10.1016\/j.addr.2026.115854_bb0470","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"nature"},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0475","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.physchem.48.1.545","article-title":"Theory of protein folding: the energy landscape perspective","volume":"48","author":"Onuchic","year":"1997","journal-title":"Annu. Rev. Phys. Chem."},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb0480","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1021\/cr000058w","article-title":"Designing protein energy landscapes","volume":"101","author":"Saven","year":"2001","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0485","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12551-013-0104-4","article-title":"Soft interactions and crowding","volume":"5","author":"Sarkar","year":"2013","journal-title":"Biophys. Rev."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0490","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/antib2030452","article-title":"Developments and challenges for mAb-based therapeutics","volume":"2","author":"Goswami","year":"2013","journal-title":"Antibodies"},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0495","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/138920105775159313","article-title":"Colloidal behavior of proteins: effects of the second virial coefficient on solubility, crystallization and aggregation of proteins in aqueous solution","volume":"6","author":"Valente","year":"2005","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0500","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1021\/acs.molpharmaceut.3c00090","article-title":"The relationship between protein\u2013protein interactions and liquid\u2013liquid phase separation for monoclonal antibodies","volume":"20","author":"Sibanda","year":"2023","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0505","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/1078155219868516","article-title":"Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag","volume":"26","author":"Sundaramurthi","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.addr.2026.115854_bb0510","series-title":"Stable Formulations of Programmed Death Receptor 1 (PD-1) Antibodies and Hyaluronidase Variants and Fragments Thereof and Methods of Use Thereof","author":"Krishnamachari","year":"2022"},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb0515","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41594-019-0238-6","article-title":"The peptide hormone glucagon forms amyloid fibrils with two coexisting \u03b2-strand conformations","volume":"26","author":"Gelenter","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.addr.2026.115854_bb0520","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijpharm.2018.06.023","article-title":"Chemical modifications of insulin: finding a compromise between stability and pharmaceutical performance","volume":"547","author":"Akbarian","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0525","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1063\/1.1727029","article-title":"Effect of volume exclusion on the dimensions of polymer chains","volume":"44","author":"Flory","year":"1966","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb0530","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jps.20417","article-title":"Influence of macromolecular crowding upon the stability and state of association of proteins: predictions and observations","volume":"94","author":"Minton","year":"2005","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb0535","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1074\/jbc.M110429200","article-title":"Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II","volume":"277","author":"Hatters","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.addr.2026.115854_bb0540","doi-asserted-by":"crossref","first-page":"9829","DOI":"10.1021\/acs.jpcb.0c07175","article-title":"Investigating the effects of molecular crowding on the kinetics of protein aggregation","volume":"124","author":"Schreck","year":"2020","journal-title":"J. Phys. Chem. B"},{"issue":"18","key":"10.1016\/j.addr.2026.115854_bb0545","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1021\/ja200067p","article-title":"Protein crowding tunes protein stability","volume":"133","author":"Miklos","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"33","key":"10.1016\/j.addr.2026.115854_bb0550","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1021\/bi100727y","article-title":"Volume exclusion and soft interaction effects on protein stability under crowded conditions","volume":"49","author":"Miklos","year":"2010","journal-title":"Biochemistry"},{"issue":"21","key":"10.1016\/j.addr.2026.115854_bb0555","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.1021\/ja201206t","article-title":"Macromolecular crowding fails to fold a globular protein in cells","volume":"133","author":"Schlesinger","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"40","key":"10.1016\/j.addr.2026.115854_bb0560","doi-asserted-by":"crossref","first-page":"16614","DOI":"10.1021\/ja305300m","article-title":"Macromolecular crowding and protein stability","volume":"134","author":"Wang","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb0565","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1021\/acs.jpclett.3c00271","article-title":"Macromolecular crowding by polyethylene glycol reduces protein breathing","volume":"14","author":"Chu","year":"2023","journal-title":"The journal of physical chemistry letters"},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0570","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4573","article-title":"Resolving the enthalpy of protein stabilization by macromolecular crowding","volume":"32","author":"Stewart","year":"2023","journal-title":"Protein Sci."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb0575","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1021\/acs.biochem.6b01251","article-title":"Cosolute and crowding effects on a side-by-side protein dimer","volume":"56","author":"Guseman","year":"2017","journal-title":"Biochemistry"},{"issue":"43","key":"10.1016\/j.addr.2026.115854_bb0580","doi-asserted-by":"crossref","first-page":"10965","DOI":"10.1073\/pnas.1810054115","article-title":"Protein shape modulates crowding effects","volume":"115","author":"Guseman","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70062","article-title":"Crowding beyond excluded volume: a tale of two dimers","volume":"34","author":"Olgenblum","year":"2025","journal-title":"Protein Sci."},{"issue":"48","key":"10.1016\/j.addr.2026.115854_bb0590","doi-asserted-by":"crossref","first-page":"18976","DOI":"10.1073\/pnas.0705127104","article-title":"Molecular crowding enhances native structure and stability of \u03b1\/\u03b2 protein flavodoxin","volume":"104","author":"Stagg","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0595","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/acs.jpclett.1c03794","article-title":"Preferential interactions of a crowder protein with the specific binding site of a native protein complex","volume":"13","author":"Dong","year":"2022","journal-title":"The journal of physical chemistry letters"},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb0600","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1021\/ja211115q","article-title":"Protein crowding affects hydration structure and dynamics","volume":"134","author":"Harada","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0605","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-physiol-042222-025920","article-title":"Molecular crowding: physiologic sensing and control","volume":"86","author":"Subramanya","year":"2024","journal-title":"Annu. Rev. Physiol."},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb0610","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1021\/acs.molpharmaceut.5c01406","article-title":"A Dehydration\u2013Diffusion Competition Framework Predicts Interfacial Film Risk in High-Concentration Biologics Fill-Finish","volume":"22","author":"Lin","year":"2025","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb0615","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.bpj.2014.10.051","article-title":"Connecting the dots: the effects of macromolecular crowding on cell physiology","volume":"107","author":"Mour\u00e3o","year":"2014","journal-title":"Biophys. J."},{"key":"10.1016\/j.addr.2026.115854_bb0620","doi-asserted-by":"crossref","first-page":"1153996","DOI":"10.3389\/fmolb.2023.1153996","article-title":"Revitalizing an important field in biophysics: the new frontiers of molecular crowding","volume":"10","author":"Cammarata","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"57","key":"10.1016\/j.addr.2026.115854_bb0625","first-page":"13049","article-title":"Temperature, hydrostatic pressure, and osmolyte effects on liquid\u2013liquid phase separation in protein condensates: physical chemistry and biological implications. Chemistry\u2013a","volume":"25","author":"Cinar","year":"2019","journal-title":"Eur. J. Dermatol."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0630","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cell.2018.12.035","article-title":"Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates","volume":"176","author":"Alberti","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0635","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-physchem-071819-113553","article-title":"Biomolecular phase separation: from molecular driving forces to macroscopic properties","volume":"71","author":"Dignon","year":"2020","journal-title":"Annu. Rev. Phys. Chem."},{"issue":"16","key":"10.1016\/j.addr.2026.115854_bb0640","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.3390\/ijms21165908","article-title":"Liquid\u2013liquid phase separation in crowded environments","volume":"21","author":"Andr\u00e9","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s41048-018-0078-7","article-title":"Protocol for analyzing protein liquid\u2013liquid phase separation","volume":"5","author":"Wang","year":"2019","journal-title":"Biophys. Rep."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0650","doi-asserted-by":"crossref","DOI":"10.1063\/5.0137008","article-title":"Study liquid\u2013liquid phase separation with optical microscopy: a methodology review","volume":"7","author":"Zhang","year":"2023","journal-title":"APL bioengineering"},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0655","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41392-021-00678-1","article-title":"Liquid\u2013liquid phase separation in human health and diseases","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0660","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1021\/jp065608u","article-title":"Comparison between protein\u2212 polyethylene glycol (PEG) interactions and the effect of PEG on protein\u2212 protein interactions using the liquid\u2212 liquid phase transition","volume":"111","author":"Wang","year":"2007","journal-title":"J. Phys. Chem. B"},{"issue":"11","key":"10.1016\/j.addr.2026.115854_bb0665","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1016\/j.bpj.2010.10.040","article-title":"Liquid-liquid phase separation of a monoclonal antibody and nonmonotonic influence of Hofmeister anions","volume":"99","author":"Mason","year":"2010","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0670","doi-asserted-by":"crossref","first-page":"7165387","DOI":"10.1155\/2022\/7165387","article-title":"Liquid-liquid phase separation promotes protein aggregation and its implications in Ferroptosis in Parkinson\u2019s disease dementia","volume":"2022","author":"Li","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"30","key":"10.1016\/j.addr.2026.115854_bb0675","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1073\/pnas.1008353107","article-title":"Phase behavior of mixtures of human lens proteins gamma D and Beta B1","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb0680","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.bpj.2017.08.048","article-title":"Metastability gap in the phase diagram of monoclonal IgG antibody","volume":"113","author":"Rowe","year":"2017","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0685","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12247-019-09414-3","article-title":"Challenges and considerations in development and manufacturing of high concentration biologics drug products","volume":"15","author":"Sahin","year":"2020","journal-title":"J. Pharm. Innov."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0690","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-biophys-121219-081629","article-title":"Physical principles underlying the complex biology of intracellular phase transitions","volume":"49","author":"Choi","year":"2020","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.addr.2026.115854_bb0695","series-title":"Phase-Separated Biomolecular Condensates: Methods and Protocols","first-page":"95","article-title":"An introduction to the stickers-and-spacers framework as applied to biomolecular condensates","author":"Ginell","year":"2022"},{"issue":"6478","key":"10.1016\/j.addr.2026.115854_bb0700","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.aaw8653","article-title":"Valence and patterning of aromatic residues determine the phase behavior of prion-like domains","volume":"367","author":"Martin","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0705","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2017.02.027","article-title":"Stress-triggered phase separation is an adaptive, evolutionarily tuned response","volume":"168","author":"Riback","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0710","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s42004-020-0328-8","article-title":"Dehydration entropy drives liquid-liquid phase separation by molecular crowding","volume":"3","author":"Park","year":"2020","journal-title":"Communications Chemistry"},{"key":"10.1016\/j.addr.2026.115854_bb0715","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1940666","article-title":"Stability of a high-concentration monoclonal antibody solution produced by liquid\u2013liquid phase separation","volume":"13","author":"Bramham","year":"2021","journal-title":"MAbs"},{"issue":"50","key":"10.1016\/j.addr.2026.115854_bb0720","doi-asserted-by":"crossref","first-page":"16013","DOI":"10.1021\/jp409300j","article-title":"Coarse-grained model for colloidal protein interactions, B 22, and protein cluster formation","volume":"117","author":"Blanco","year":"2013","journal-title":"J. Phys. Chem. B"},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb0725","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1021\/acs.molpharmaceut.7b00418","article-title":"Investigating liquid\u2013liquid phase separation of a monoclonal antibody using solution-state NMR spectroscopy: effect of Arg\u00b7 Glu and Arg\u00b7 HCl","volume":"14","author":"Kheddo","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115854_bb0730","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2550757","article-title":"Mechanistic and predictive formulation development for viscosity mitigation of high-concentration biotherapeutics","volume":"17","author":"Cruz","year":"2025","journal-title":"mAbs"},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0735","doi-asserted-by":"crossref","DOI":"10.1063\/1.4955162","article-title":"Rheology of clustering protein solutions","volume":"10","author":"Dharmaraj","year":"2016","journal-title":"Biomicrofluidics"},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0740","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1039\/C9SM01953G","article-title":"Potential and limits of a colloid approach to protein solutions","volume":"16","author":"Stradner","year":"2020","journal-title":"Soft Matter"},{"key":"10.1016\/j.addr.2026.115854_bb0745","article-title":"Impact of electroviscous effect on viscosity in developing highly concentrated protein formulations: lessons from non-protein charged colloids","volume":"1","author":"Li","year":"2019","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb0750","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1002\/jps.21322","article-title":"Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab\u2013Fab interaction that impacts solution viscosity","volume":"97","author":"Kanai","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0755","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.xphs.2018.10.031","article-title":"Syringe filling of a high-concentration mAb formulation: experimental, theoretical, and computational evaluation of filling process parameters that influence the propensity for filling needle clogging","volume":"108","author":"Hanslip","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0760","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.xphs.2021.09.016","article-title":"Syringe filling of high-concentration mAb products using peristaltic pump-based mechanism: challenges and mitigation strategies","volume":"111","author":"Desai","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb0765","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5731\/pdajpst.2014.00973","article-title":"Filling of high-concentration monoclonal antibody formulations into pre-filled syringes: filling parameter investigation and optimization","volume":"68","author":"Shieu","year":"2014","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0770","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/membranes12010026","article-title":"Recent mitigation strategies on membrane fouling for oily wastewater treatment","volume":"12","author":"Zulkefli","year":"2021","journal-title":"Membranes"},{"key":"10.1016\/j.addr.2026.115854_bb0775","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2026208","article-title":"Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeutics","volume":"14","author":"Lai","year":"2022","journal-title":"MAbs"},{"key":"10.1016\/j.addr.2026.115854_bb0780","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/19420862.2017.1285479","article-title":"In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions","volume":"9","author":"Tomar","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.addr.2026.115854_bb0785","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.csbj.2022.04.035","article-title":"DeepSCM: an efficient convolutional neural network surrogate model for the screening of therapeutic antibody viscosity","volume":"20","author":"Lai","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.addr.2026.115854_bb0790","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.csbj.2024.05.029","article-title":"DeepSP: deep learning-based spatial properties to predict monoclonal antibody stability","volume":"23","author":"Kalejaye","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.addr.2026.115854_bb0795","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2483944","article-title":"Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning","volume":"17","author":"Kalejaye","year":"2025","journal-title":"MAbs"},{"issue":"25","key":"10.1016\/j.addr.2026.115854_bb0800","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1021\/acs.jpcb.9b04478","article-title":"X-ray scattering and coarse-grained simulations for clustering and interactions of monoclonal antibodies at high concentrations","volume":"123","author":"Dear","year":"2019","journal-title":"J. Phys. Chem. B"},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0805","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1021\/acs.jpcb.2c07616","article-title":"Characterizing experimental monoclonal antibody interactions and clustering using a coarse-grained simulation library and a viscosity model","volume":"127","author":"Chowdhury","year":"2023","journal-title":"J. Phys. Chem. B"},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0810","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1021\/acs.molpharmaceut.3c00023","article-title":"Subclass effects on self-association and viscosity of monoclonal antibodies at high concentrations","volume":"20","author":"Chowdhury","year":"2023","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.addr.2026.115854_bb0815","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1021\/acs.molpharmaceut.3c00484","article-title":"Characterizing protein\u2013protein interactions and viscosity of a monoclonal antibody from low to high concentration using small-angle x-ray scattering and molecular dynamics simulations","volume":"20","author":"Chowdhury","year":"2023","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0820","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/s41467-023-38039-x","article-title":"Engineering protein-based therapeutics through structural and chemical design","volume":"14","author":"Ebrahimi","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0825","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-2859-4-29","article-title":"Directed evolution strategies for improved enzymatic performance","volume":"4","author":"Hibbert","year":"2005","journal-title":"Microb. Cell Factories"},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3906\/biy-1809-28","article-title":"Protein engineering approaches for antibody fragments: directed evolution and rational design approaches","volume":"43","author":"Arslan","year":"2019","journal-title":"Turk. J. Biol."},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb0835","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/jps.24520","article-title":"Rational design of biobetters with enhanced stability","volume":"104","author":"Courtois","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0840","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.copbio.2019.01.008","article-title":"Selecting and engineering monoclonal antibodies with drug-like specificity","volume":"60","author":"Starr","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"issue":"11","key":"10.1016\/j.addr.2026.115854_bb0845","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1002\/jps.24130","article-title":"Improving monoclonal antibody selection and engineering using measurements of colloidal protein interactions","volume":"103","author":"Geng","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0850","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2171248","article-title":"Assessing developability early in the discovery process for novel biologics","volume":"15","author":"Fern\u00e1ndez-Quintero","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.addr.2026.115854_bb0855","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2543771","article-title":"Enhanced rational protein engineering to reduce viscosity in high-concentration IgG1 antibody solutions","volume":"17","author":"Lefevre","year":"2025","journal-title":"MAbs"},{"key":"10.1016\/j.addr.2026.115854_bb0860","doi-asserted-by":"crossref","first-page":"1257665","DOI":"10.3389\/fbioe.2023.1257665","article-title":"Decreasing hydrophobicity or shielding hydrophobic areas of CH2 attenuates low pH-induced IgG4 aggregation","volume":"11","author":"Wu","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0865","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/aic.13995","article-title":"Directed evolution: past, present, and future","volume":"59","author":"Cobb","year":"2013","journal-title":"AICHE J."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb0870","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrg3927","article-title":"Methods for the directed evolution of proteins","volume":"16","author":"Packer","year":"2015","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0875","doi-asserted-by":"crossref","DOI":"10.1002\/aic.16814","article-title":"Directed evolution methods for overcoming trade-offs between protein activity and stability","volume":"66","author":"Stimple","year":"2020","journal-title":"AICHE J."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0880","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-chembioeng-062011-081052","article-title":"Engineering aggregation-resistant antibodies","volume":"3","author":"Perchiacca","year":"2012","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0885","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.sbi.2007.08.007","article-title":"Phage display for engineering and analyzing protein interaction interfaces","volume":"17","author":"Sidhu","year":"2007","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb0890","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.sbi.2007.08.012","article-title":"Yeast surface display for protein engineering and characterization","volume":"17","author":"Gai","year":"2007","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"supplement_1","key":"10.1016\/j.addr.2026.115854_bb0895","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1073\/pnas.0901522106","article-title":"The light of directed evolution: pathways of adaptive protein evolution","volume":"106","author":"Bloom","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7873","key":"10.1016\/j.addr.2026.115854_bb0900","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"nature"},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0905","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4653","article-title":"Novo protein design by inversion of the AlphaFold structure prediction network","volume":"32","author":"Goverde","year":"2023","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0910","doi-asserted-by":"crossref","first-page":"28266","DOI":"10.1038\/s41598-025-13527-w","article-title":"Prediction of aggregation in monoclonal antibodies from molecular surface curvature","volume":"15","author":"Knez","year":"2025","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.addr.2026.115854_bb0915","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2017.07.057","article-title":"Optimization of high-concentration endostatin formulation: harmonization of excipients\u2019 contributions on colloidal and conformational stabilities","volume":"530","author":"Wang","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb0920","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.xphs.2023.03.026","article-title":"The evolution of commercial antibody formulations","volume":"112","author":"Mieczkowski","year":"2023","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.addr.2026.115854_bb0925","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1021\/acs.molpharmaceut.2c00453","article-title":"Understanding the stabilizing effect of histidine on mAb aggregation: a molecular dynamics study","volume":"19","author":"Saurabh","year":"2022","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb0930","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/acs.molpharmaceut.1c00373","article-title":"Antibodies with weakly basic isoelectric points minimize trade-offs between formulation and physiological colloidal properties","volume":"19","author":"Gupta","year":"2022","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb0935","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1021\/acs.molpharmaceut.8b00210","article-title":"The effect of low ionic strength on diffusion and viscosity of monoclonal antibodies","volume":"15","author":"Pindrus","year":"2018","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0940","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/acs.biomac.3c01001","article-title":"Combined Effects of Pressure and Ionic Strength on Protein\u2013Protein Interactions: An Empirical Approach","volume":"25","author":"Paul","year":"2023","journal-title":"Biomacromolecules"},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb0945","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.xphs.2022.05.011","article-title":"Viscosity reduction and stability enhancement of monoclonal antibody formulations using derivatives of amino acids","volume":"111","author":"Srivastava","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0950","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2521511","article-title":"Temperature and excipient mediated modulation of monoclonal antibody interactions revealed by k D, rheology, and Raman spectroscopy","volume":"17","author":"Eskens","year":"2025","journal-title":"mAbs"},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb0955","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.xphs.2023.03.009","article-title":"Effect of various silicone oil and tungsten levels on the stability of a monoclonal antibody in nine commercially available prefilled syringes","volume":"112","author":"Murphy","year":"2023","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb0960","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1002\/jps.21190","article-title":"Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways","volume":"97","author":"Kerwin","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb0965","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejpb.2015.09.016","article-title":"Key interactions of surfactants in therapeutic protein formulations: a review","volume":"97","author":"Khan","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.addr.2026.115854_bb0970","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijpharm.2018.10.008","article-title":"Polysorbate degradation in biotherapeutic formulations: identification and discussion of current root causes","volume":"552","author":"Dwivedi","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115854_bb0975","doi-asserted-by":"crossref","first-page":"1490276","DOI":"10.3389\/fbioe.2024.1490276","article-title":"Polysorbates degrading enzymes in biotherapeutics\u2013a current status and future perspectives","volume":"12","author":"Felix","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb0980","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s11095-011-0385-x","article-title":"The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics","volume":"28","author":"Kishore","year":"2011","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.addr.2026.115854_bb0985","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.xphs.2021.05.012","article-title":"Polysorbate degradation and particle formation in a high concentration mAb: formulation strategies to minimize effect of enzymatic polysorbate degradation","volume":"110","author":"Roy","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0990","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.xphs.2019.10.069","article-title":"Comparison of polysorbate 80 hydrolysis and oxidation on the aggregation of a monoclonal antibody","volume":"109","author":"Larson","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-012-9878-0","article-title":"Effect of polysorbate 80 concentration on thermal and photostability of a monoclonal antibody","volume":"14","author":"Agarkhed","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"22","key":"10.1016\/j.addr.2026.115854_bb1000","doi-asserted-by":"crossref","first-page":"11917","DOI":"10.1073\/pnas.94.22.11917","article-title":"Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state","volume":"94","author":"Kendrick","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"14","key":"10.1016\/j.addr.2026.115854_bb1005","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1016\/S0021-9258(19)68947-7","article-title":"The stabilization of proteins by sucrose","volume":"256","author":"Lee","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2026.115854_bb1010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijbiomac.2017.12.089","article-title":"Preferential exclusion mechanism by carbohydrates on protein stabilization using thermodynamic evaluation","volume":"109","author":"Kim","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"32","key":"10.1016\/j.addr.2026.115854_bb1015","doi-asserted-by":"crossref","first-page":"21215","DOI":"10.1039\/D3CP02639F","article-title":"New insights into the protein stabilizing effects of trehalose by comparing with sucrose","volume":"25","author":"Ahlgren","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jps.21797","article-title":"Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation","volume":"99","author":"Salinas","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1025","doi-asserted-by":"crossref","first-page":"2200102","DOI":"10.1002\/adtp.202200102","article-title":"Stable high-concentration monoclonal antibody formulations enabled by an amphiphilic copolymer excipient","volume":"6","author":"Klich","year":"2023","journal-title":"Advanced therapeutics"},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb1030","doi-asserted-by":"crossref","first-page":"2409604","DOI":"10.1002\/advs.202409604","article-title":"Defining structure-function relationships of amphiphilic excipients enables rational Design of Ultra-Stable Biopharmaceuticals","volume":"12","author":"Prossnitz","year":"2025","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb1035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17101328","article-title":"Short peptides as excipients in parenteral protein formulations: a Mini review","volume":"17","author":"Migo\u0144","year":"2025","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb1040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12551-018-0407-6","article-title":"Ionic liquids as biocompatible stabilizers of proteins","volume":"10","author":"Reslan","year":"2018","journal-title":"Biophys. Rev."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1045","doi-asserted-by":"crossref","DOI":"10.1002\/cpps.62","article-title":"Computational methods for predicting protein-protein interactions using various protein features","volume":"93","author":"Ding","year":"2018","journal-title":"Curr. Protoc. Protein Sci."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb1050","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1021\/acs.chemrev.3c00550","article-title":"Computational approaches to predict protein\u2013protein interactions in crowded cellular environments","volume":"124","author":"Grassmann","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2026.115854_bb1055","article-title":"Characterizing protein-protein interactions in mAb formulations: a comparative study of kD, B22, and DLVO framework","author":"Parnian","year":"2025","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/abt\/tbab003","article-title":"Optimization of therapeutic antibodies","volume":"4","author":"Wang","year":"2021","journal-title":"Antibody therapeutics"},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb1065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tips.2020.12.004","article-title":"Machine learning for biologics: opportunities for protein engineering, developability, and formulation","volume":"42","author":"Narayanan","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"42","key":"10.1016\/j.addr.2026.115854_bb1070","doi-asserted-by":"crossref","first-page":"13426","DOI":"10.1021\/jp108399g","article-title":"Interaction of arginine with proteins and the mechanism by which it inhibits aggregation","volume":"114","author":"Shukla","year":"2010","journal-title":"J. Phys. Chem. B"},{"issue":"41","key":"10.1016\/j.addr.2026.115854_bb1075","doi-asserted-by":"crossref","first-page":"11831","DOI":"10.1021\/jp204462t","article-title":"Understanding the synergistic effect of arginine and glutamic acid mixtures on protein solubility","volume":"115","author":"Shukla","year":"2011","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.addr.2026.115854_bb1080","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2427771","article-title":"Residue-resolved insights into the stabilization of therapeutic proteins by excipients: a case study of two monoclonal antibodies with arginine and glutamate","volume":"16","author":"Prass","year":"2024","journal-title":"mAbs"},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb1085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/abt\/tbad022","article-title":"Effects of arginine in therapeutic protein formulations: a decade review and perspectives","volume":"6","author":"Ren","year":"2023","journal-title":"Antibody therapeutics"},{"key":"10.1016\/j.addr.2026.115854_bb1090","series-title":"Process for obtaining renatured proteins US Patent 4933434","author":"Rudolph","year":"1990"},{"issue":"29","key":"10.1016\/j.addr.2026.115854_bb1095","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1021\/ja049297h","article-title":"A simple method for improving protein solubility and long-term stability","volume":"126","author":"Golovanov","year":"2004","journal-title":"J. Am. Chem. Soc."},{"issue":"46","key":"10.1016\/j.addr.2026.115854_bb1100","doi-asserted-by":"crossref","first-page":"18713","DOI":"10.1021\/ja205215t","article-title":"Complex interactions between molecular ions in solution and their effect on protein stability","volume":"133","author":"Shukla","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb1105","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1021\/acs.molpharmaceut.5b00643","article-title":"Viscosity-lowering effect of amino acids and salts on highly concentrated solutions of two IgG1 monoclonal antibodies","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/acs.molpharmaceut.5c01496","article-title":"Surface charge and solvent exposure dictate the pH-dependent viscosity of therapeutic antibodies","volume":"23","author":"Jiang","year":"2025","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.addr.2026.115854_bb1115","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.xphs.2021.06.030","article-title":"Caffeine as a viscosity reducer for highly concentrated monoclonal antibody solutions","volume":"110","author":"Zeng","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb1120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/bit.22983","article-title":"Hydrophobic salts markedly diminish viscosity of concentrated protein solutions","volume":"108","author":"Du","year":"2011","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.addr.2026.115854_bb1125","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/19420862.2017.1358328","article-title":"Preferential interactions of trehalose, L-arginine. HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies","volume":"9","author":"Sudrik","year":"2017","journal-title":"MAbs"},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb1130","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1021\/jp808042w","article-title":"Investigation of cosolute\u2212 protein preferential interaction coefficients: new insight into the mechanism by which arginine inhibits aggregation","volume":"113","author":"Schneider","year":"2009","journal-title":"J. Phys. Chem. B"},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb1135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/jacs.6b11082","article-title":"Guanidinium can both cause and prevent the hydrophobic collapse of biomacromolecules","volume":"139","author":"Heyda","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"22","key":"10.1016\/j.addr.2026.115854_bb1140","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1021\/jp111920y","article-title":"Arginine and the Hofmeister series: the role of ion\u2013ion interactions in protein aggregation suppression","volume":"115","author":"Schneider","year":"2011","journal-title":"J. Phys. Chem. B"},{"issue":"51","key":"10.1016\/j.addr.2026.115854_bb1145","doi-asserted-by":"crossref","first-page":"15895","DOI":"10.1021\/ja074719j","article-title":"The reversal by sulfate of the denaturant activity of guanidinium","volume":"129","author":"Dempsey","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb1150","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.3390\/molecules20059214","article-title":"Aromatic amino acids-guanidinium complexes through cation-\u03c0 interactions","volume":"20","author":"Trujillo","year":"2015","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb1155","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1039\/C7SC04905F","article-title":"Cation\u2013\u03c0 interactions in protein\u2013ligand binding: theory and data-mining reveal different roles for lysine and arginine","volume":"9","author":"Kumar","year":"2018","journal-title":"Chem. Sci."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb1160","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.xphs.2021.11.018","article-title":"Arginine and its derivatives suppress the opalescence of an antibody solution","volume":"111","author":"Oki","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb1165","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jbiosc.2013.10.016","article-title":"Arginine and lysine reduce the high viscosity of serum albumin solutions for pharmaceutical injection","volume":"117","author":"Inoue","year":"2014","journal-title":"J. Biosci. Bioeng."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb1170","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2398-1","article-title":"Improving viscosity and stability of a highly concentrated monoclonal antibody solution with concentrated proline: Hung et al","volume":"35","author":"Hung","year":"2018","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb1175","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/molecules27030999","article-title":"Influence of low molecular weight salts on the viscosity of aqueous-buffer bovine serum albumin solutions","volume":"27","author":"Zdovc","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb1180","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s12010-017-2413-8","article-title":"Viscosity-reducing bulky-salt excipients prevent gelation of protein, but not carbohydrate, solutions","volume":"182","author":"Kumar","year":"2017","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"21","key":"10.1016\/j.addr.2026.115854_bb1185","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/bi900080d","article-title":"Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from 13C, 31P, and 19F solid-state NMR","volume":"48","author":"Su","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2026.115854_bb1190","series-title":"Viscosity Reduction of Highly Concentrated Protein Formulations","author":"Zillmann","year":"2021"},{"key":"10.1016\/j.addr.2026.115854_bb1195","series-title":"Camphorsulfonic Acid and Combinations Thereof with Cationic Excipients as Viscosity Reducing Agents in High Concentrated Protein Formulations","author":"Rosenkranz","year":"2022"},{"key":"10.1016\/j.addr.2026.115854_bb1200","series-title":"Compounds for Reducing the Viscosity of Biological Formulations","author":"Chu","year":"2020"},{"key":"10.1016\/j.addr.2026.115854_bb1205","series-title":"Methods for Reducing the Viscosity of Liquid Pharmaceutical Formulations Comprising Therapeutic Proteins","author":"Sloey","year":"2023"},{"key":"10.1016\/j.addr.2026.115854_bb1210","series-title":"Process for Lowering the Viscosity of Highly Concentrated Protein Solutions","author":"Dauty","year":"2016"},{"key":"10.1016\/j.addr.2026.115854_bb1215","series-title":"Liquid Protein Formulations Containing Ionic Liquids","author":"Larson","year":"2024"},{"key":"10.1016\/j.addr.2026.115854_bb1220","series-title":"Excipients to Reduce the Viscosity of Antibody Formulations and Formulation Compositions","author":"Gu","year":"2018"},{"key":"10.1016\/j.addr.2026.115854_bb1225","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1016\/j.csbj.2022.09.035","article-title":"Discovery of compounds with viscosity-reducing effects on biopharmaceutical formulations with monoclonal antibodies","volume":"20","author":"Proj","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.addr.2026.115854_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124055","article-title":"The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions","volume":"655","author":"Pra\u0161nikar","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"812","key":"10.1016\/j.addr.2026.115854_bb1235","doi-asserted-by":"crossref","first-page":"eadv6427","DOI":"10.1126\/scitranslmed.adv6427","article-title":"Ultrahigh-concentration biologic therapeutics enabled by spray drying with a glassy surfactant excipient","volume":"17","author":"Jons","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2026.115854_bb1240","article-title":"High-concentration antibody formulation via solvent-based dehydration","author":"Zheng","year":"2025","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb1245","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/jps.23847","article-title":"Microglassificationtm: a novel technique for protein dehydration","volume":"103","author":"Gaul","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb1250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejpb.2021.01.014","article-title":"Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins","volume":"161","author":"Marschall","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.xphs.2022.06.016","article-title":"Drug product characterization of high concentration non-aqueous protein powder suspensions","volume":"112","author":"Marschall","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115854_bb1260","first-page":"1","article-title":"SC delivery of ultra-high concentration (up to 500 mg\/mL) protein microparticle suspensions: pharmacokinetics, efficacy, biodistribution, and immunogenicity","author":"Shadbar","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2026.115854_bb1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123616","article-title":"Reversible protein complexes as a promising avenue for the development of high concentration formulations of biologics","volume":"648","author":"Dahmana","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb1275","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.xphs.2023.10.021","article-title":"Stability comparison between microglassification and lyophilization using a monoclonal antibody","volume":"113","author":"Chandrababu","year":"2024","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb1280","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/btpr.621","article-title":"Crystallization and liquid-liquid phase separation of monoclonal antibodies and fc-fusion proteins: screening results","volume":"27","author":"Trilisky","year":"2011","journal-title":"Biotechnol. Prog."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1285","doi-asserted-by":"crossref","DOI":"10.1038\/s41526-019-0090-3","article-title":"Pembrolizumab microgravity crystallization experimentation","volume":"5","author":"Reichert","year":"2019","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.addr.2026.115854_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101325","article-title":"Structural principles of insulin formulation and analog design: a century of innovation","volume":"52","author":"Jarosinski","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb1295","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acs.molpharmaceut.1c00915","article-title":"Investigating crystalline protein suspension formulations of pembrolizumab from MAS NMR spectroscopy","volume":"19","author":"Li","year":"2022","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb1300","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nsmb.3129","article-title":"Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab","volume":"22","author":"Scapin","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb1305","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1021\/acs.molpharmaceut.4c00418","article-title":"Small-angle X-ray scattering as a powerful tool for phase and crystallinity assessment of monoclonal antibody crystallites in support of batch crystallization","volume":"21","author":"Larpent","year":"2024","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb1310","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mrc.5536","article-title":"Quantitative solid-state NMR spectroscopy (qSSNMR) in pharmaceutical analysis","volume":"63","author":"Zheng","year":"2025","journal-title":"Magn. Reson. Chem."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb1315","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/gels11070520","article-title":"Dual-Drug Delivery Systems Using Hydrogel\u2013Nanoparticle Composites: Recent Advances and Key Applications","volume":"11","author":"Yoon","year":"2025","journal-title":"Gels"},{"issue":"11","key":"10.1016\/j.addr.2026.115854_bb1320","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1039\/C5TB02137E","article-title":"Protein release from highly charged peptide hydrogel networks","volume":"4","author":"Nagy-Smith","year":"2016","journal-title":"J. Mater. Chem. B"},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb1325","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C1SM06513K","article-title":"Shear-thinning hydrogels for biomedical applications","volume":"8","author":"Guvendiren","year":"2012","journal-title":"Soft Matter"},{"issue":"28","key":"10.1016\/j.addr.2026.115854_bb1330","doi-asserted-by":"crossref","first-page":"17531","DOI":"10.1021\/acsomega.0c02009","article-title":"In situ forming injectable thermoresponsive hydrogels for controlled delivery of biomacromolecules","volume":"5","author":"Dutta","year":"2020","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1335","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1039\/D4PM00290C","article-title":"Injectable sustained-release hydrogel for high-concentration antibody delivery","volume":"2","author":"Zheng","year":"2025","journal-title":"RSC Pharmaceutics"},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb1340","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107452","article-title":"Injectable hydrogel particles for amorphous solid formulation of biologics","volume":"26","author":"Erfani","year":"2023","journal-title":"iScience"},{"issue":"15","key":"10.1016\/j.addr.2026.115854_bb1345","doi-asserted-by":"crossref","first-page":"2202370","DOI":"10.1002\/adhm.202202370","article-title":"Crystalline antibody-laden alginate particles: a platform for enabling high concentration subcutaneous delivery of antibodies","volume":"12","author":"Erfani","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"11","key":"10.1016\/j.addr.2026.115854_bb1350","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1080\/17425247.2021.1981286","article-title":"Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery","volume":"18","author":"Knowles","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2026.115854_bb1355","article-title":"An industry perspective on hyaluronidase co-formulated biopharmaceutics","author":"Guo","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1360","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2252999","article-title":"Identifying a predictive relationship between maximal flow rate and viscosity for subcutaneous administration of macromolecules with recombinant human hyaluronidase PH20 in a miniature pig model","volume":"30","author":"Connor","year":"2023","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb1365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254765","article-title":"Dispersive effects and focused biodistribution of recombinant human hyaluronidase PH20: a locally acting and transiently active permeation enhancer","volume":"16","author":"Kang","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb1370","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/17425247.2021.1853699","article-title":"Development of syringes and vials for delivery of biologics: current challenges and innovative solutions","volume":"18","author":"Yoneda","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2026.115854_bb1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114901","article-title":"Improving prefilled syringe injectability: influences of critical component attributes and human factors","author":"Wang","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2026.115854_bb1380","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115793","article-title":"High concentration subcutaneous biological drug products: challenges and advancements","author":"Hu","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115854_bb1385","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5c01652","article-title":"Mechanistic investigation of Zn (II) extraction and interactions in combination biological drug products","author":"Song","year":"2026","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb1395","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/jps.24387","article-title":"Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes","volume":"104","author":"Gerhardt","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.addr.2026.115854_bb1400","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.xphs.2023.05.017","article-title":"Variables impacting silicone oil migration and biologics in prefilled syringes","volume":"112","author":"Gentile","year":"2023","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb1405","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.xphs.2025.01.025","article-title":"Centrifuge siliconization of primary container systems","volume":"114","author":"Wong","year":"2025","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1410","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.xphs.2019.05.018","article-title":"Characterization of protein aggregates, silicone oil droplets, and protein-silicone interactions using imaging flow cytometry","volume":"109","author":"Probst","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb1415","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jps.21982","article-title":"Protein adsorption and excipient effects on kinetic stability of silicone oil emulsions","volume":"99","author":"Ludwig","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.addr.2026.115854_bb1420","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/jps.21719","article-title":"Silicone oil-and agitation-induced aggregation of a monoclonal antibody in aqueous solution","volume":"98","author":"Thirumangalathu","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb1425","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jps.20321","article-title":"Silicone oil induced aggregation of proteins","volume":"94","author":"Jones","year":"2005","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb1430","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.xphs.2022.09.015","article-title":"The impact of syringe age prior to filling on migration of subvisible silicone-oil particles into drug product","volume":"111","author":"Song","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb1435","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/jps.23973","article-title":"Protein aggregation and particle formation in prefilled glass syringes","volume":"103","author":"Gerhardt","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.addr.2026.115854_bb1440","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1021\/acs.langmuir.0c02785","article-title":"Monoclonal antibody aggregation near silicone oil\u2013water interfaces","volume":"37","author":"Dandekar","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2026.115854_bb1445","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5c01837","article-title":"Molecular mechanisms of Liraglutide aggregation induced by dual air-water and silicone-oil-water interfacial stress","author":"Hamada","year":"2026","journal-title":"Mol. Pharm."},{"issue":"45","key":"10.1016\/j.addr.2026.115854_bb1450","doi-asserted-by":"crossref","first-page":"30102","DOI":"10.1021\/acs.langmuir.5c02823","article-title":"Shear and Dilatational Rheology and Interfacial Structure of a Monoclonal Antibody Adsorbed at the Air\u2013Liquid Interface","volume":"41","author":"Pham","year":"2025","journal-title":"Langmuir"},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb1455","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1021\/acs.molpharmaceut.5c01406","article-title":"A Dehydration\u2013Diffusion Competition Framework Predicts Interfacial Film Risk in High-Concentration Biologics Fill-Finish","volume":"22","author":"Lin","year":"2025","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.addr.2026.115854_bb1460","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1021\/acs.molpharmaceut.2c00864","article-title":"Investigating the orientation of an interfacially adsorbed monoclonal antibody and its fragments using neutron reflection","volume":"20","author":"Ruane","year":"2023","journal-title":"Mol. Pharm."},{"issue":"35","key":"10.1016\/j.addr.2026.115854_bb1465","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg2873","article-title":"No ordinary proteins: adsorption and molecular orientation of monoclonal antibodies","volume":"7","author":"Kanthe","year":"2021","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.addr.2026.115854_bb1470","doi-asserted-by":"crossref","DOI":"10.1063\/5.0207959","article-title":"Adsorption of monoclonal antibody fragments at the water\u2013oil interface: a coarse-grained molecular dynamics study","volume":"8","author":"Saurabh","year":"2024","journal-title":"APL bioengineering"},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1475","first-page":"11","article-title":"Root cause analysis of tungsten-induced protein aggregation in pre-filled syringes","volume":"64","author":"Liu","year":"2010","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1480","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5731\/pdajpst.2015.005546","article-title":"Characterization of protein aggregating tungstates: electrospray mass spectrometry analysis of extracts from prefilled syringes and from tungsten pins used in the manufacture of syringes","volume":"70","author":"Ronk","year":"2016","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"11","key":"10.1016\/j.addr.2026.115854_bb1485","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11095-018-2496-0","article-title":"Fragmentation of a monoclonal antibody by peroxotungstate","volume":"35","author":"Rathnayaka","year":"2018","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb1490","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1002\/jps.21778","article-title":"Tungsten-induced protein aggregation: solution behavior","volume":"98","author":"Jiang","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.addr.2026.115854_bb1495","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s11095-011-0621-4","article-title":"Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity","volume":"29","author":"Seidl","year":"2012","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.addr.2026.115854_bb1500","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1208\/s12249-025-03167-8","article-title":"Alternative syringe and needle Design for Clog-free Delivery of high-concentration suspensions","volume":"26","author":"Kowsari","year":"2025","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.addr.2026.115854_bb1505","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1016\/j.xphs.2020.09.014","article-title":"Comparison of strategies in development and manufacturing of low viscosity, ultra-high concentration formulation for IgG1 antibody","volume":"109","author":"Deokar","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.addr.2026.115854_bb1510","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1080\/17425247.2020.1796630","article-title":"User experience for manual injection of 2 mL viscous solutions is enhanced by a new prefillable syringe with a staked 8 mm ultra-thin wall needle","volume":"17","author":"Pager","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.addr.2026.115854_bb1515","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.xphs.2019.10.033","article-title":"Assessment of the injection performance of a tapered needle for use in prefilled biopharmaceutical products","volume":"109","author":"Krayukhina","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb1520","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/jps.23947","article-title":"Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics","volume":"103","author":"Depaz","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"18","key":"10.1016\/j.addr.2026.115854_bb1530","article-title":"Enhancing the injectability of high concentration drug formulations using core annular flows","volume":"9","author":"Jayaprakash","year":"2020","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.addr.2026.115854_bb1535","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/jps.23945","article-title":"Functional evaluation and characterization of a newly developed silicone oil-free prefillable syringe system","volume":"103","author":"Yoshino","year":"2014","journal-title":"J. Pharm. Sci."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:00:19Z","timestamp":1775581219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X26000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":303,"alternative-id":["S0169409X26000888"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115854","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein stability and viscosity in molecularly crowded high-concentration biologics","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115854"}}